Le Lézard
Classified in: Health
Subjects: AWD, NPT

DaVita VillageHealth Receives Disease Management Recertification


DENVER, Oct. 10, 2017 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, today announced  that DaVita VillageHealth received a three-year recertification award from the National Committee for Quality Assurance (NCQA) under the Disease Management Certification.

"NCQA's Disease Management Accreditation program is thorough and rigorous. It's designed to highlight only those programs that truly improve chronic care," said NCQA President Margaret E. O'Kane. "DaVita VillageHealth's unwavering commitment to improving care for renal patients is demonstrated by its high-quality services and continuous operational improvements, which have translated into notable positive outcomes for patients 15 years running."

The full recertification denotes that as a disease management program, DaVita VillageHealth has passed a voluntary, intense three-year review process where the NCQA examines member and practitioner services, coordination of care, program operations, evidence-based guidelines and measurement and quality improvement. The high standards encourage disease management organizations to continuously enhance the quality of services they deliver, while reducing patient risk. No other comparable evaluation exists for disease management programs.

"We have helped empower and support more than 64,000 patients through our integrated care programs," commented Todd Ezrine, general manager for DaVita VillageHealth. "The NCQA recognition reflects our continued performance in delivering high-quality, integrated care to help manage the unique and complex needs of our patients and achieve the triple aim working together with our partners."

Through collaborative care coordination and education, DaVita VillageHealth offers personalized care to help address the individual needs of every patient. This proven approach can result in an enhanced patient experience, a reduction in cost and an improvement in a patient's overall quality of health and life.

NCQA Accreditation standards are developed with input from researchers in the field, the Disease Management Advisory Council and standing committees, employers, both purchasers and operators of disease management programs, state and federal regulators and other experts.

About DaVita VillageHealth
As the country's largest NCQA-accredited renal provider, VillageHealth® is the integrated care division of DaVita Kidney Care. VillageHealth's 600 teammates serve more than 20,000 end-stage renal disease (ESRD) and late-stage chronic kidney disease (CKD) patients each month. By partnering with health plans, the government, health systems and nephrologists, VillageHealth measurably improves clinical outcomes, enhances patient experience, and reduces total cost of care for renal populations participating in its integrated care programs. VillageHealth's partnership models include traditional fee-for-service, shared savings, and fully-delegated risk arrangements. VillageHealth has been fully capitated in the industry's longest-running Medicare Advantage ESRD Chronic Condition Special Needs Plan (C-SNP) since 2011 and now operates twelve ESRD C-SNPs, three ESRD Seamless Care Organizations (ESCOs), as well as more than a dozen programs with commercial payors and health systems. For more information, please visit VillageHealth.com.

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita Inc., a Fortune 500® company, that through its operating divisions provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams, and convenient health-management services. As of June 30, 2017, DaVita Kidney Care operated or provided administrative services at 2,445 outpatient dialysis centers located in the United States serving approximately 194,600 patients. The company also operated 217 outpatient dialysis centers located in 11 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek, and WorldBlu. For more information, please visit DaVita.com.

About NCQA
NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA is committed to providing health care quality information for consumers, purchasers, health care providers, and researchers. For more information, please visit NCQA.org.

 

Contact Information

Media:
Ashley Henson
[email protected]
303-876-6626

DaVita Inc. (PRNewsfoto/DaVita Kidney Care)

 

SOURCE DaVita Kidney Care


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: